Supports cellular homeostasis
• Scientifically shown to help reduce chronic pain and inflammation
• A naturally occurring long-chain fatty acid amide generally produced in response to various triggers including inflammation
• Provides a multipronged approach to activating and sustaining the endocannabinoid system
• Studied for 80 years and by more than 300+ medical studies
• Capsules for your convenience
PRODUCT DESCRIPTION
Palmitoylethanolamide (PEA) is a long-chain fatty acid naturally produced by the body but also found in foods such as egg yolk, soy, and sunflower oils. This molecule, researched for its unique and varied health benefits for eighty years, is now receiving attention because of its crucial role in the endocannabinoid system (ECS). The ECS is a lipid communication network with critical physiological functions. It is a signaling network that communicates with other systems throughout the body, helping to regulate them. PEA is an endocannabinoid produced locally by the cells and it accumulates in tissues following any injury, physical stress, or pain.
By inhibiting the activation of mast cells that cause additional inflammation (such as the release of histamine), PEA acts as a potent anti-inflammatory agent. This unique molecule has other direct and indirect mechanisms of action; it even enhances the action of other endocannabinoids through its “entourage effect”. The PEA molecule has been clinically demonstrated to relieve pain in osteoarthritis of the knee as well as to reduce symptoms of low back pain. This mighty little molecule is well tolerated by athletes, children, and seniors.
AOR ADVANTAGE
The PEA in AOR’s P.E.A.k Activate is produced in Italy and originally extracted from environmentally sustainable Malaysian palm oil that is purified and responsibly processed for optimal bioavailability
Adult Dosage:
Take one capsule three times daily with or without food; or as directed by a qualified health care practitioner.
Cautions:
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner for use beyond 40 days or if symptoms persist or worsen.
